MediConnect, a health solutions provider, has announced that the firm is working on a blockchain-based platform to curb the issues related to overprescribing of medicines and enhance patient safety.

According to the company, Stratis Group Ltd. will build a suite of tailored services for the MediConnect blockchain platform. The platform is claimed to ensure visibility and transparency into drug distribution in online pharmacies.

As stated, the solution will comprise of a private permissioned blockchain to store confidential data and a public blockchain to process transactions made via MEDI tokens. Consequently, the tokens will enable patients to earn discounts and rewards thereby reducing the costs of healthcare services.

Initially, two online pharmacies will implement the platform in the middle of 2019 to validate the efficiency of the platform. Later, the firm has plans to expand the platform on a larger scale.